Health Protection Surveillance Centre, Dublin, Ireland; Vaccine European New Integrated Collaboration Effort (VENICE) Project, Italy.
Vaccine. 2010 Jun 17;28(28):4470-7. doi: 10.1016/j.vaccine.2010.04.037. Epub 2010 May 6.
In January 2009 25 European Union (EU) Member States (MSs), Norway and Iceland, participated in a survey seeking information on national hepatitis B vaccination programmes. Details of vaccination policy, schedule, population groups targeted for vaccination, programme funding, vaccine coverage and methods of monitoring of vaccine coverage were obtained. Twenty (74%) countries reported that they have a universal hepatitis B vaccination programme, in addition to immunisation of at risk groups; seven (26%) countries recommend HBV for high risk groups only (with some inter-country variation on groups considered at high risk). Among countries without universal hepatitis B vaccination programmes, the major factor for non-introduction is low disease endemicity.
2009 年 1 月,25 个欧盟成员国、挪威和冰岛参与了一项调查,旨在获取有关国家乙型肝炎疫苗接种计划的信息。调查获得了疫苗接种政策、时间表、目标人群、计划资金、疫苗覆盖率以及疫苗覆盖率监测方法等方面的详细信息。20 个(74%)国家报告称,除了对高危人群进行免疫接种外,它们还实施了乙型肝炎普遍疫苗接种计划;7 个(26%)国家仅向高危人群推荐乙肝疫苗(各国对高危人群的界定存在差异)。在未实施乙型肝炎普遍疫苗接种计划的国家中,不引入该计划的主要原因是疾病低流行率。